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OBJECTIVE — The purpose of this study was to compare the incidence of vascular lower-
limb amputation (LLA) in the diabetic and nondiabetic general population.
RESEARCH DESIGN AND METHODS — A population-based cohort study was con-
ducted in a representative Swedish region. All vascular LLAs (at or proximal to the transmeta-
tarsallevel)performedfrom1997through2006wereconsecutivelyregisteredandclassiﬁedinto
initial unilateral amputation, contralateral amputation, or reamputation. The incidence rates
were estimated in the diabetic and nondiabetic general population aged 45 years.
RESULTS — During the 10-year period, LLA was performed on 62 women and 71 men with
diabetes and on 79 women and 78 men without diabetes. The incidence of initial unilateral
amputation per 100,000 person-years was 192 (95% CI 145–241) for diabetic women, 197
(152–244) for diabetic men, 22 (17–26) for nondiabetic women, and 24 (19–29) for nondia-
betic men. The incidence increased from the age of 75 years. Of all amputations, 74% were
transtibial. The incidences of contralateral amputation and of reamputation per 100 amputee-
years in diabetic women amputees were 15 (7–27) and 16 (8–28), respectively; in diabetic men
amputees 18 (10–29) and 21 (12–32); in nondiabetic women amputees 14 (7–24) and 18
(10–28); and in nondiabetic men amputees 13 (6–22) and 24 (15–35).
CONCLUSIONS — Inthegeneralpopulationaged45years,theincidenceofvascularLLA
at or proximal to the transmetatarsal level is eight times higher in diabetic than in nondiabetic
individuals. One in four amputees may require contralateral amputation and/or reamputation.
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S
evere peripheral arterial disease in-
dicating critical ischemia has been
found in 1.2% of a general popula-
tion aged 60 years (1) and in almost 5%
of primary care patients aged 65 years
(2). It has been reported that one in four
diabetic individuals develops peripheral
vascular disease that, when severe, may
require amputation (3). Estimating the
incidenceofvascularlower-limbamputa-
tion (LLA) in diabetic and nondiabetic
individuals can provide important infor-
mation regarding changes in the inci-
dence over time. This can assist in the
planningofpreventativecareandrehabil-
itation and facilitate assessment of the ef-
fects of interventions, such as arterial
reconstructionandamputationatspeciﬁc
levels, and the success of prosthetic reha-
bilitation (4,5).
ThereportedannualincidenceofLLA
related to peripheral vascular disease has
ranged from approximately 20 to 35 per
100,000 inhabitants (5,6). These inci-
dence rates were usually based on the to-
tal population rather than on age-groups
of the diabetic or the nondiabetic general
population in which severe peripheral
vascular disease usually occurs (7). Fur-
thermore, different deﬁnitions and inci-
dence estimation methods have been
used, and problems of incorrectly regis-
tered diagnoses and missing data have
beendescribed(3,8).Individualswithdi-
abeteshaveaccountedforlessthanhalfof
all patients with LLA in studies from Fin-
land and Sweden (5,9) but for as much as
two-thirds of patients with LLA in a Ger-
man general population study (6).
Compared with amputations in non-
diabetic individuals, amputations due to
diabetes have more often involved
younger individuals and lower amputa-
tion levels (10). Because vascular LLA in
diabetic and nondiabetic individuals may
differ with regard to patient characteris-
tics,initialamputationlevel,clinicalman-
agement, and prognosis (including
mortality rates), it is important to study
the epidemiology of LLA related to pe-
ripheral vascular disease with and with-
out diabetes independently (10). Few
population-based studies have estimated
the incidence of LLA in the diabetic gen-
eral population based on validated data
concerning the age- and sex-speciﬁc
prevalence of diabetes at the time of
study. Despite the availability of data on
amputations (11), the utility of these data
to accurately determine the incidence of
LLAinthegeneralpopulationmaybelim-
ited because the data are usually based
on hospital discharges, which do not ac-
curately detail procedures performed and
concurrent diagnosis of diabetes. More-
over, accurate incidence rates cannot be
derived unless the data are related to val-
idated estimates of the sex- and age-
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general population.
The aim of this population-based co-
hort study was to estimate the incidence
of LLA (at or proximal to the transmeta-
tarsal level) performed for peripheral vas-
cular disease among the diabetic and the
nondiabeticgeneralpopulationovera10-
yearperiod,withparticularconsideration
of the rate of reamputation and contralat-
eral amputation.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted on a representative population in
Northeastern Scania, a health care district
in the southern part of Sweden with a to-
tal population of 170,000. All LLAs in
this region are performed at one orthope-
dic department by orthopedic surgeons,
and patients considered for amputation
related to vascular disease are assessed in
agreement with vascular surgeons.
The inclusion criteria for this study
were amputation performed because of
peripheral vascular disease with or with-
out diabetes at or proximal to the trans-
metatarsal level during the period from 1
January 1997 through 31 December
2006. Patients with infection as the pri-
mary diagnosis and peripheral vascular
disease as the secondary diagnosis were
also included. The exclusion criteria were
residence outside the study region at the
time of amputation (according to the na-
tional population register), toe or ray am-
putations, and amputation performed for
other reasons such as trauma or tumor.
Thenumberofdiabeticindividualsin
the general population was estimated on
thebasisoftheage-andsex-speciﬁcprev-
alence of diabetes in the region of O ¨ ster-
go ¨tland in the southeast area of Sweden.
In that population, the prevalence of dia-
beteswasdeterminedusingacase-ﬁnding
algorithm that retrospectively searched
for the diagnosis of diabetes during a
5-year period (1999–2003) in the re-
gion’s administrative database (12). The
tworegionshavesimilarpopulationchar-
acteristics (13).
Data collection
All patients undergoing LLA in the oper-
ating room were recorded consecutively.
The surgical procedure was recorded ac-
cording to the Nordic Classiﬁcation of
Surgical Procedures (codes NEQ 19–
NHQ 14) and included amputation level,
side, and diagnosis. The amputations were
classiﬁed according to the following deﬁni-
tions: an initial unilateral amputation is an
individual’s ﬁrst LLA at or proximal to the
transmetatarsal level (including secondary
closure or two-stage amputation); a con-
tralaterallimbamputationisanamputation
at or proximal to the transmetatarsal level
on the opposite lower limb in an individual
whohadundergoneaninitialunilateralam-
putation; and a reamputation is a new am-
putationatamoreproximallevel(including
proceduresinwhichbonelengthwasshort-
ened within the same level) in a individual
whohadundergoneaninitialunilateralora
contralateral limb amputation.
Patients were considered to be dia-
betic if they had a diagnosis of diabetes
treated with oral hypoglycemic agents or
insulin at the time of amputation. Infor-
mation from all medical records was ﬁrst
documented by one investigator (A.J.)
and then veriﬁed by a second investigator
(G.-U.L.). All postoperative care and new
surgical procedures were performed at the
study region’s hospital. No patients in-
cluded in the study moved from the region
during the study period. The regional ethi-
cal committee at Lund University approved
the study.
Statistical analysis
The overall sex- and age-speciﬁc inci-
denceratesfortheinitialunilateralampu-
tation were calculated for diabetic and
nondiabetic individuals. Because only
one diabetic individual aged 45 years
(aged 44 years and 9 months at amputa-
tion) and no nondiabetic individuals un-
derwent amputation at or proximal to the
transmetatarsal level during the study pe-
riod, the incidence rates were calculated
for the diabetic and nondiabetic popula-
tions aged 45 years. All patients were
residing in the region during the study
period. The mean 10-year diabetic and
nondiabetic populations were calculated
as the mean value for the population for
each year of the study period (obtained
from the national population statistical
database), adjusted for the prevalence of
diabetes. The overall incidence per
100,000 person-years was calculated as
the number of diabetic and nondiabetic
individuals aged 45 years who had un-
dergone initial unilateral amputation di-
vided by the corresponding total
population. The number of amputations
over a 10-year period was assumed to
have a Poisson distribution and the num-
ber of individuals with diabetes to have a
binomial distribution (these were as-
sumed to be independent). Parametric
bootstrap analysis with 10,000 replica-
tions and the percentile method were
used to estimate 95% CIs for incidence
rate. Incidence rates for contralateral am-
putation and reamputation among indi-
viduals who had undergone an initial
unilateralamputationwerecalculatedper
100 amputee-years. In calculating the in-
cidence rates (initial unilateral, contralat-
eral, and reamputation), each patient
accounted for no more than one amputa-
tion for each incidence rate. The 1-year
mortality rates among diabetic and non-
diabetic patients were compared using
Cox regression analysis with adjustment
for age and sex. For patients included
during the ﬁnal year of the study, mortal-
ity was recorded during 1 year after am-
putation. A Kaplan-Meier analysis was
used to calculate median time from initial
amputation to death. P  0.05 was con-
sidered to indicate statistical signiﬁcance.
The analyses were performed with SPSS
14.0(SPSS,Chicago,IL)andSTATA10.0
(StataCorp, College Station, TX).
RESULTS— During the 10-year study
period, 133 diabetic patients (53% men)
and 157 nondiabetic patients (50% men)
underwent initial unilateral amputations
at or proximal to the transmetatarsal level
because of peripheral vascular disease
(Table 1). Among these patients, a con-
tralaterallimbamputationwasperformed
on 22 (17%) of the diabetic patients and
on 21 (13%) of the nondiabetic patients.
A reamputation was performed after the
initial unilateral amputation in 20 dia-
betic patients (15%) and after the con-
tralateral amputation in 5 patients (3.8%);
the corresponding numbers among the
nondiabetic patients were 27 (17%) and
6 (3.8%). Patients 75 years of age com-
prised62%ofthediabeticand81%ofthe
nondiabetic group. The amputation was
performed at the transtibial level or more
distally in 120 (90%) of the diabetic pa-
tients and in 116 (74%) of the nondia-
betic patients.
Incidence
Duringthe10-yearstudyperiodthemean
midyear population of individuals aged
45 years in the study region was
76,322, and the prevalence of diabetes
was 9% (total diabetic population aged
45 years 6,841 and nondiabetic popu-
lation 69,480). The overall incidence of
initial unilateral amputation in the dia-
betic population was 195 (95% CI 163–
231)per100,000person-yearsandinthe
nondiabetic population was 23 (19–26)
per 100,000 person-years (Table 2).
Amongdiabeticindividualsofbothsexes,
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age, with similar incidence rates between
45 and 85 years, after which the inci-
dence in men was threefold that in
women. In the 85 years age-group the
incidence in men was ﬁve times as high
and in women twice as high as the inci-
dence rate in the general population of all
ages. Among nondiabetic individuals, the
incidence was low up to age 75 years but
increased sharply thereafter and in the
85 years age-group the incidence in
menwas15timesandinwomen12times
as high as the incidence in the total pop-
ulation of all ages.
Contralateral limb amputation
Theincidenceofcontralateralamputation
amongdiabeticamputeeswas17(95%CI
10–25) per 100 amputee-years and
among nondiabetic amputees was 13 (8–
20)per100amputee-years(Table3).The
most frequent contralateral amputation
level among diabetic and nondiabetic pa-
tients was transtibial. Thirteen diabetic
patients (10%) and 10 nondiabetic pa-
tients (6%) became bilateral transtibial
amputees.
Reamputation
The incidence of reamputation among di-
abetic amputees was 19 (95% CI 12–28)
per 100 amputee-years and among non-
diabeticamputeeswas14(9–22)peram-
putee-years (Table 3). The most frequent
reamputation level among diabetic pa-
tients was transtibial and among nondia-
betic patients was transfemoral. Among
initial transtibial amputees, reamputation
Table 1—Characteristics of the study population stratiﬁed into diabetic and nondiabetic patients according to initial unilateral amputation,
contralateral amputation, and reamputation
Diabetic Nondiabetic
Initial unilateral
amputation
Contralateral
amputation Reamputation*
Initial unilateral
amputation
Contralateral
amputation Reamputation*
n 133 22 25 157 21 33
Women 62 (47) 9 (41) 10 (40) 79 (50) 11 (52) 14 (42)
Age (years) 77  98 3  8‡
Men 71 (53) 13 (59) 15 (60) 78 (50) 10 (48) 19 (58)
Age (years) 76  11 79  8†
Level
Transfemoral 7 (5) 1 (5) 11 (44) 25 (16) 5 (24) 26 (79)
Knee disarticulation 6 (5) 2 (9) 16 (10) 1 (5) 3 (9)
Transtibial 108 (81)§ 17 (77) 13 (52) 109 (69)§ 15 (71)§ 4 (12)
Midfoot (including tarsometatarsal
joints)
5 (4) 1 (5) 1 (4) 2 (1)
Transmetatarsal 7 (5) 1 (5) 5 (3)
DataaremeansSDorn(%).*Reamputation(includingbonerevision).†P0.001comparedwithdiabeticpatients.‡P0.007comparedwithdiabeticpatients.
§Including one ankle disarticulation.
Table 2—Incidence (per 100,000 person-years) of initial unilateral amputation at or proximal to the transmetatarsal level in the diabetic and
nondiabetic general population
Age-group
Prevalence of
diabetes
Diabetic Nondiabetic
No. of
persons Population Incidence (95% CI)
No. of
persons Population Incidence (95% CI)
Women
45–64 years 4.3 7 9,277 75 (22–138) 0 — —
65–74 (55–74) years 11.3 (8.0†) 11 9,179 120 (55–197) 11† 172,465 7† (3–10†)
75–84 years 14.7 30 10,100 297 (194–408) 34 58,769 58 (39–78)
85 years 13.4 14 4,256 329 (167–518) 34 27,548 123 (83–167)
Population 45 years‡ 8.1 62 32,307‡ 192 (145–241) 79 367,337‡ 22 (17–26)
Total population 4.1 62 35,260 176 (134–221) 79 822,365 10 (8–12)
Men
45–64 years 6.8 11 15,133 73 (33–117) 0 — —
65–74 (55–74) years 14.6 (11.4†) 21 10,813 194 (118–282) 19† 161,088† 12† (7–17)†
75–84 years 16.7 19 8,551 222 (129–328) 39 42,767 91 (63–121)
85 years 14.3 20 2,153 929 (545–1,369) 20 12,945 154 (92–225)
Population 45 years‡ 9.9 71 36,105‡ 197 (152–244 78 327,467‡ 24 (19–29)
Total population 4.6 71 38,860 183 (142–226 78 800,303 10 (8–12)
*Per100,000person-years.†Thevaluesarefortheage-group55–74yearsbecausenolowerlimbamputationwasperformedonnondiabeticpersonsaged55years
(CIs could only be calculated for the wider age interval because of small numbers). ‡All person-years generated by persons at risk do not sum to equal because this
would imply that prevalence would be constant over age-groups.
Johannesson and Associates
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patients and 16 (15%) of the nondiabetic
patients.
The time from initial amputation to
reamputation showed no statistically sig-
niﬁcant differences between sexes in both
groups, whereas the time to contralateral
amputation was shorter in nondiabetic
patients and tended to be shorter for men
in both groups (Table 3).
Mortality
After an initial amputation, the median
survivaltimefordiabeticpatientswas440
(95% CI 303–577) days and for nondia-
beticpatientswas563(95%CI368–758)
days. During the ﬁrst year after the initial
amputation, 60 diabetic patients (45%)
and 78 nondiabetic patients (50%) died.
The 1-year mortality did not differ signif-
icantly between the two groups, with an
age- and sex adjusted odds ratio of 1.03
(95% CI 0.73–1.46, P  0.87).
CONCLUSIONS — This study
showed that the incidence rate of initial
unilateral LLA at or proximal to the trans-
metatarsal level in the general population
aged45yearswasmorethaneighttimes
higher among diabetic individuals than
among nondiabetic individuals. When
the incidence rate is calculated on the ba-
sis of the general population of all ages,
the incidence of initial amputation due to
diabetes would be 179 per 100,000 per-
son-years and that due to peripheral arte-
rial disease in nondiabetic individuals
would be 10 per 100,000 person-years.
The incidence rate in the nondiabetic
population is similar to that reported in
previous studies. A rate of 9 per 100,000
person-years was reported in a German
city population with a mean age 10 years
lower than that for our study population
(6), and a rate of 12 per 100,000 person-
years was reported in a Dutch population
(14). However, a Finnish study has re-
ported a higher incidence of 23 per
100,000 person-years (15).
For the diabetic population, more
disparity is observed when our incidence
rate is compared with that reported in
previous studies. This is probably due to
differencesinmethodology(14)and/orin
accuracy of the diabetes prevalence data
used (6) and whether the data had been
validated (12). In the German population
study, relatively old data concerning the
prevalence of diabetes were used, and the
incidence rate (230 per 100,000 person-
years) was higher than that estimated in
our study. However, an incidence of 247
per100,000person-yearswasreportedin
apopulationofaScottishcitywithamean
age similar to that of the German popula-
tion and with diabetes prevalence data
that had been validated (16). Approxi-
mately one-third of all amputations in
bothstudiesweretoeamputations,which
were not included in our study. A study
that compared continuous registration of
all amputations with the ofﬁcial patient
register reported that only 36% of the di-
abetes-related amputations were noted in
the ofﬁcial register and that the ﬁnding
was in agreement with that in several
other studies (8). Missing data are more
likely to involve toe or ray-level amputa-
tions, as they are often performed in an
emergency room or outpatient clinic and
therefore are not registered in the surgical
databases. The potentially high number
of missing amputations can substantially
inﬂuence the comparability of incidence
rates in studies that do not exclude toe
and ray amputation. Another aspect
that needs to be considered is whether
the incidence rate of diabetes-related
LLA was based on the initial (ﬁrst) am-
putation or the highest level of amputa-
tion performed on patients who had
undergone more than one amputation
(6). In some cases, the initial amputa-
tion is performed on a nondiabetic in-
dividual, but the last amputation is
performed after a diagnosis of diabetes
has been established.
TheincidenceofvascularLLAmaybe
dependent on the age characteristics of
the study population (7). The incidence
of amputation among individuals aged
80 years has been reported to be almost
threefold that among individuals aged
60–80 years (6). However, in our study,
differencesofsuchmagnitudewerefound
only among nondiabetic men aged 85
years compared with younger age-
groups. The incidence of amputation in
both the diabetic and the nondiabetic
general population would be much lower
if the rate were based on the total popu-
lation of all ages rather than on the age-
groups in which amputations were
performed. Because amputation at the
transmetatarsal level or higher, related to
diabetes and/or peripheral arterial dis-
ease, is extremely uncommon in individ-
uals aged 45 years, the incidence rate
based on the population aged 45 years
is probably more clinically important.
It has been suggested that the inci-
dence of diabetes among adults in Swe-
den has not increased, although the
prevalence has increased mainly because
ofahighermedianageofdiabeticindivid-
uals in the general population (17). The
incidence of amputation in this Swedish
population increased with age in both
men and women, but the mean age at ini-
tial amputation was lower for men than
for women—a ﬁnding also shown in
other studies (18). Our study showed a
signiﬁcantlyhigherriskforamputationin
diabetic men aged 85 years. A Finnish
populationstudyshowedthatmenhavea
signiﬁcantlyhigherriskofvascularampu-
tation than women (15).
In our study, the incidence rate based
Table 3—Contralateral amputation and reamputation at or proximal to the transmetatarsal level in diabetic and nondiabetic amputees
Diabetic Nondiabetic
n Incidence*
Time from initial
amputation (days) n Incidence*
Time from initial
amputation (days)
Contralateral amputation
Women 9 15 (7.0–26) 614 (224–1,223) 11 14 (7.2–24) 260 (140–399)
Men 13 18 (10–29) 273 (60–466) 10 13 (6.3–22) 49 (1–290)
Reamputation
Women 10 16 (8.0–28) 30 (10–82) 14 18 (10–28) 30 (14–65)
Men 15 21 (12–32) 27 (18–49) 19 24 (15–35) 23 (12–36)
Dataareincidence(95%CI)ormedian(interquartilerange).*Incidenceper100amputee-years,basedonat-riskpopulationofpatientswithpriorinitialamputation
at or proximal to the transmetatarsal level performed during the study period (see Table 2).
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100,000 person-years, which is 35%
higher than the incidence rate of initial
amputation (17 per 100,000 person-
years). A literature review showed that in
many previous studies the reported inci-
dence rates were based on number of all
“amputations” (7), which would imply
that individuals were allowed to count
more than once and continue to accrue
person-time after the initial amputation.
Without distinguishing the initial ampu-
tationfromareamputationandcontralat-
eral amputation, the incidence rates
reported in such studies are likely to re-
ﬂect multiple procedures performed on
the same patient, which is more common
at the foot level in diabetic patients (8).
According to a study involving 10 centers
insixcountries,thedisparityinincidence
rates based on initial or on all amputa-
tions ranged from 20 to 40% but was
sometimes much higher (19).
The incidence rates of reamputation
or contralateral amputation over the 10-
year study period were similar among the
diabetic and nondiabetic men and
women amputees, ranging from 13 to 24
per 100 amputee-years. Few longitudinal
studies have presented sex-speciﬁc inci-
dence rates of reamputation after ampu-
tations proximal to the toe or ray level.
After the initial unilateral amputation,
19% of the diabetic patients and 21% of
the nondiabetic patients underwent a re-
amputation after a median period of 1
month, with approximately 90% occur-
ringwithin2months.Theresultssupport
the fact that once the amputated limb has
healed, the risk of reamputation is small
(9). Also, 17% of the diabetic initial uni-
lateral amputees became bilateral ampu-
teesafteramediantimeof1yearinmen
and 2 years in women compared with
13%ofthenondiabeticamputeesaftera
median time of 2 months in men and
9 months in women. The rate of con-
tralateral amputation is lower than re-
ported previously; Andersson (20)
reported that 31% (119 of 385) of vas-
cular amputees (mean age 63 years)
underwent contralateral amputation
within 2 years, whereas Greant and Van
denBrande(21)reportedthatone-third
of 58 patients (mean age 72 years) re-
quired a contralateral amputation after
a mean time of 8 months.
The most common level for initial am-
putation in our study was the transtibial
level; the ratio of transtibial to higher-level
amputation in diabetic patients was 8.2:1
and in nondiabetic patients was 2.6:1,
which is better than the ratio of 2.5:1 usu-
ally considered as the “gold standard” (22).
This conservative surgical approach in dia-
betic patients did not seem to increase the
reamputation rate.
The high 1-year mortality in our
study is related to the high mean age of
the study population and is consistent
withpreviousreportsfromSweden(9).In
astudyfromtheU.S.,the1-yearmortality
was 30% with a mean age of the patients
of 67 years (23).
The strengths of the present study are
that it was performed on a well-deﬁned
general population over a 10-year period,
with all amputations performed at the
same department and data veriﬁed for ac-
curacy, and that validated diabetes prev-
alence estimates from a representative
populationwereused.Onelimitationwas
that residents from the study region may
have had an amputation performed at
hospitals outside the region and were not
included. This would probably involve
very few patients because, according to
the health care system, such patients
wouldusuallybeseenforfollow-upand
rehabilitation at the regional hospital
unless they died or did not come for
follow-up. Although all of the vascular
amputations were performed by ortho-
pedic surgeons, a different practice
from that in other countries, the indica-
tion for amputation was considered in
agreementwithvascularsurgeons.Con-
sequently, the specialty of the surgeon
(vascular or orthopedic) who performs
the amputation procedure itself is not
likely to inﬂuence the incidence rates.
The use of 45 years as the lower age
limit for estimating the incidence rate in
the general population may limit compa-
rabilitywithotherstudies.However,only
onepatienthadanamputationbeforethis
age, and this age has also been shown to
be the starting point of LLA in patients
with type 1 diabetes (24). Another limita-
tion may be the exclusion of toe and ray
amputations, which may make some
comparisons with studies that classiﬁed
amputations on the basis of other criteria
more difﬁcult. However, the deﬁnitions
of “major” and “minor” amputation used
in various studies have been inconsistent,
making comparisons difﬁcult. For exam-
ple, a major amputation has been deﬁned
in various studies as one extending from
the tarsometatarsal joint (19), the “mid-
foot” (18), or the ankle (Symes) (8) and
even beginning from the transtibial level
(9). Furthermore, incidence rates based
on amputations from the transmetatarsal
level that exclude the most distal amputa-
tions are probably more accurate and
have greater clinical signiﬁcance with re-
gard to the effects on functional mobility
of the patients and the total cost of hospi-
talization (25).
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